Loading…
Loading…
ZBH · NYSE · Healthcare
“A medical device monopoly trading at 25x earnings proves that when you own the replacement parts for aging humans, pricing power beats poetry.”
— In the voice of Munger
Evaluate financial health using Piotroski F-Score criteria — profitability, leverage, and operating efficiency metrics.
Market Cap
$17.65B
P/E Ratio
25.04
Forward P/E
—
EPS
$3.56
PEG Ratio
-0.61
Book Value
$64.13
Dividend Yield
1.08%
Profit Margin
8.57%
ROE
5.55%
Use the interactive quality score with pre-loaded data for Zimmer Biomet Holdings Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for ZBH: